Association Between Serum Uric Acid with Diabetes and Other Biochemical Markers
Overview
Affiliations
Objective: This study aimed to decipher the association between serum uric acid (UA) and glycated hemoglobin (HbA1c) in the population from the southern region of Saudi Arabia.
Method: In this retrospective cross-sectional investigation, clinical data obtained from the different commercial laboratories in the Asir region of Saudi Arabia were screened over 2 years. Data were analyzed using standard statistical methods.
Results: A total of 1984 laboratory investigations with 1215 females (61.2%) and 769 males (38.6%) were included in the data analysis. In our investigation, the prevalence of hyperuricemia in the study population was 53.5% (41.2% females and 12.3% males) and in the diabetic population was 12.7% (9.47% females and 3.23% males), in prediabetics was 12.65% (9.8% females and 2.85% males), respectively. Prediabetic subjects had higher UA levels than people with diabetes or healthy people. Higher UA quartiles were associated with a high level of urea, blood urea nitrogen (BUN) creatinine, HbA1c, fasting blood sugar (FBS), and total cholesterol (TC) ( < 0.05). High UA (OR = 1.33 for diabetes; OR = 2.676 for prediabetes), high BUN (OR = 3.05 for diabetes; OR = 2.293 for prediabetes), high TC (OR = 3.75 for diabetes; OR = 1.098 for prediabetes), and high TG (OR = 2.67 for diabetes; OR = 1.943 for prediabetes) parameters are the most influential risk factor in diabetic and prediabetic patients than the people who have normal UA, BUN, TC, and TG value.
Conclusion: High UA levels are significantly associated with prediabetes as defined by HbA1c criteria, indicating that UA has a significant role in the disturbance of glucose metabolism. A significant positive association was observed between dyslipidemia and serum UA in the study population.
Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge.
Gu W, Zhao J, Xu Y Front Immunol. 2025; 16:1512093.
PMID: 39935474 PMC: 11810932. DOI: 10.3389/fimmu.2025.1512093.
The interplay of factors in metabolic syndrome: understanding its roots and complexity.
Islam M, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M Mol Med. 2024; 30(1):279.
PMID: 39731011 PMC: 11673706. DOI: 10.1186/s10020-024-01019-y.
Patel S, Singh M, Kahlon N J Family Med Prim Care. 2024; 13(11):5040-5046.
PMID: 39723005 PMC: 11668416. DOI: 10.4103/jfmpc.jfmpc_777_24.
Alqahtani S J Family Med Prim Care. 2023; 12(7):1352-1360.
PMID: 37649774 PMC: 10465043. DOI: 10.4103/jfmpc.jfmpc_104_23.
Evaluation of levels of uric acid and lipid profile in hospitalized patients with diabetes.
Fayazi H, Mortazavi Khatibani S, Motamed B, Yaseri M BMC Res Notes. 2023; 16(1):154.
PMID: 37488643 PMC: 10367241. DOI: 10.1186/s13104-023-06429-5.